These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26223692)

  • 41. Relationship between osteoprotegerin and mortality in decompensated heart failure with preserved ejection fraction.
    Aramburu-Bodas Ó; García-Casado B; Salamanca-Bautista P; Guisado-Espartero ME; Arias-Jiménez JL; Barco-Sánchez A; Santamaría-González JC; Formiga F; Montero-Pérez-Barquero M; Manzano L
    J Cardiovasc Med (Hagerstown); 2015 Jun; 16(6):438-43. PubMed ID: 25469731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study.
    Carlsen CM; Bay M; Kirk V; Gøtze JP; Køber L; Nielsen OW
    Eur J Heart Fail; 2012 Mar; 14(3):240-7. PubMed ID: 22315457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional status and co-morbidities are associated with in-hospital mortality among older patients with acute decompensated heart failure: a multicentre prospective cohort study.
    Le Corvoisier P; Bastuji-Garin S; Renaud B; Mahé I; Bergmann JF; Perchet H; Paillaud E; Mottier D; Montagne O
    Age Ageing; 2015 Mar; 44(2):225-31. PubMed ID: 25313242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of cardiopulmonary dysfunction and left atrial remodeling in development of acute decompensated heart failure in chronic heart failure with preserved left ventricular ejection fraction.
    Kaneko H; Koike A; Senoo K; Tanaka S; Suzuki S; Nagayama O; Sagara K; Otsuka T; Matsuno S; Funada R; Uejima T; Oikawa Y; Yajima J; Nagashima K; Kirigaya H; Sawada H; Aizawa T; Yamashita T
    J Cardiol; 2012 May; 59(3):359-65. PubMed ID: 22421198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of acute delirium as a predictor of adverse outcomes in patients >65 years of age with acute decompensated heart failure.
    Uthamalingam S; Gurm GS; Daley M; Flynn J; Capodilupo R
    Am J Cardiol; 2011 Aug; 108(3):402-8. PubMed ID: 21757045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].
    Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three-dimensional echocardiography in the diagnosis of myocardial infarction and its correlation with the expressions of serum HIF-1α, HO-1 and VEGF.
    Yu Q; Li L; Zhao N
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2751-2756. PubMed ID: 29771427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low Insulin Is an Independent Predictor of All-Cause and Cardiovascular Death in Acute Decompensated Heart Failure Patients Without Diabetes Mellitus.
    Nogi M; Kawakami R; Ishihara S; Hirai K; Nakada Y; Nakagawa H; Ueda T; Nishida T; Onoue K; Soeda T; Okayama S; Watanabe M; Saito Y
    J Am Heart Assoc; 2020 May; 9(10):e015393. PubMed ID: 32406318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship Between Serum Sodium Level Within the Low-Normal Range on Admission and Long-Term Clinical Outcomes in Patients with Acute Decompensated Heart Failure.
    Hiki M; Kasai T; Yatsu S; Murata A; Matsumoto H; Kato T; Suda S; Miyazaki T; Takagi A; Daida H
    Int Heart J; 2018 Sep; 59(5):1052-1058. PubMed ID: 30101847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term survival after hospitalization for acute heart failure--differences in prognosis of acutely decompensated chronic and new-onset acute heart failure.
    Lassus JP; Siirilä-Waris K; Nieminen MS; Tolonen J; Tarvasmäki T; Peuhkurinen K; Melin J; Pulkki K; Harjola VP;
    Int J Cardiol; 2013 Sep; 168(1):458-62. PubMed ID: 23073273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure.
    Andersen IA; Huntley BK; Sandberg SS; Heublein DM; Burnett JC
    Nephrol Dial Transplant; 2016 May; 31(5):767-72. PubMed ID: 26666498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosis.
    Baggish AL; van Kimmenade RR; Pinto Y; Richards AM; Lainchbury J; Bayes-Genis A; Santaló M; Ordonez-Llanos J; Januzzi JL
    Biomarkers; 2010 Jun; 15(4):307-14. PubMed ID: 20370326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure.
    Chuang CP; Jong YS; Wu CY; Lo HM
    Am J Cardiol; 2014 Mar; 113(5):845-50. PubMed ID: 24406111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure.
    Davutoglu V; Yildirim C; Kucukaslan H; Yuce M; Sari I; Tarakcioglu M; Akcay M; Cakici M; Ceylan N; Al B
    Kardiol Pol; 2010 Jul; 68(7):771-8. PubMed ID: 20648434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.
    Goonewardena SN; Gemignani A; Ronan A; Vasaiwala S; Blair J; Brennan JM; Shah DP; Spencer KT
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):595-601. PubMed ID: 19356487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive cutoff point of admission N-terminal pro-B-type natriuretic peptide testing in the ED for prognosis of patients with acute heart failure.
    Golcuk Y; Golcuk B; Velibey Y; Oray D; Atilla OD; Colak A; Kurtulmus Y; Yildirim A; Eren M
    Am J Emerg Med; 2013 Aug; 31(8):1191-5. PubMed ID: 23759684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma interleukin-6 level is associated with NT-proBNP level and predicts short- and long-term mortality in patients with acute heart failure.
    Pudil R; Tichý M; Andrýs C; Rehácek V; Bláha V; Vojácek J; Palicka V
    Acta Medica (Hradec Kralove); 2010; 53(4):225-8. PubMed ID: 21400981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction.
    Lok DJ; Klip IT; Voors AA; Lok SI; Bruggink-André de la Porte PW; Hillege HL; Jaarsma T; van Veldhuisen DJ; van der Meer P
    Eur J Heart Fail; 2014 Sep; 16(9):958-66. PubMed ID: 25082741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Should procalcitonin be measured routinely in acute decompensated heart failure?
    Loncar G; Tscholl V; Tahirovic E; Sekularac N; Marx A; Obradovic D; Veskovic J; Lainscak M; von Haehling S; Edelmann F; Arandjelovic A; Apostolovic S; Stanojevic D; Pieske B; Trippel T; Dungen HD
    Biomark Med; 2015; 9(7):651-9. PubMed ID: 26174839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.